Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk
Authors:
- 1 February 2008
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (2) , 291-296
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The intrinsic pathway of coagulation: a target for treating thromboembolic disease?Journal of Thrombosis and Haemostasis, 2007
- Evidence of a U‐shaped association between factor XII activity and overall survivalJournal of Thrombosis and Haemostasis, 2007
- The 46C→T polymorphism in the factor XII gene (F12) and the risk of venous thrombosisJournal of Thrombosis and Haemostasis, 2005
- Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Reevaluation of the Incidence of Thromboembolic Complications in Congenital Factor XII DeficiencyThrombosis and Haemostasis, 1999
- FXII (46C→T) Polymorphism and In Vivo Generation of FXII ActivityThrombosis and Haemostasis, 1999
- Measurement of activated factor XII in health and diseaseBlood Coagulation & Fibrinolysis, 1996
- Hageman factor and risk of myocardial infarction in middle-aged menAtherosclerosis, 1992
- Factor XII clotting activity and antigen levels in patients with thromboembolic diseaseBlood Coagulation & Fibrinolysis, 1992
- An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAsNucleic Acids Research, 1987